275 related articles for article (PubMed ID: 1376749)
1. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
Golay J; Cusmano G; Introna M
J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
[TBL] [Abstract][Full Text] [Related]
2. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
3. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
5. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
6. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
7. The A-Myb transcription factor is a marker of centroblasts in vivo.
Golay J; Broccoli V; Lamorte G; Bifulco C; Parravicini C; Pizzey A; Thomas NS; Delia D; Ferrauti P; Vitolo D; Introna M
J Immunol; 1998 Mar; 160(6):2786-93. PubMed ID: 9510180
[TBL] [Abstract][Full Text] [Related]
8. Activation of dense human tonsilar B cells. Induction of c-myc gene expression via two distinct signal transduction pathways.
White MW; McConnell F; Shu GL; Morris DR; Clark EA
J Immunol; 1991 Feb; 146(3):846-53. PubMed ID: 1703181
[TBL] [Abstract][Full Text] [Related]
9. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
Klemsz MJ; Justement LB; Palmer E; Cambier JC
J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
[TBL] [Abstract][Full Text] [Related]
10. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
Catron KM; Purkerson JM; Isakson PC; Bender TP
J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes with potential nuclear function: myc, myb and fos.
Eisenman RN; Thompson CB
Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
[TBL] [Abstract][Full Text] [Related]
12. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
13. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
14. B cell early response gene expression coupled to B cell receptor, CD40 and interleukin-4 receptor co-stimulation: evidence for a role of the egr-2/krox 20 transcription factor in B cell proliferation.
Newton JS; Li J; Ning ZQ; Schoendorf DE; Norton JD; Murphy JJ
Eur J Immunol; 1996 Apr; 26(4):811-6. PubMed ID: 8625972
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of C alpha 1 and C alpha 2 germ-line and mature mRNA transcripts in human peripheral blood B cells.
Kitani A; Strober W
J Immunol; 1994 Aug; 153(4):1466-77. PubMed ID: 8046226
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
17. Inducible cell contact signals regulate early activation gene expression during B-T lymphocyte collaboration.
Klaus SJ; Parker DC
J Immunol; 1992 Sep; 149(6):1867-75. PubMed ID: 1387663
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
Satterwhite DJ; Aakre ME; Gorska AE; Moses HL
Cell Growth Differ; 1994 Aug; 5(8):789-99. PubMed ID: 7986745
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
20. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
